Literature DB >> 12372094

Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease.

T I Kaya1, H Dur, U Tursen, A Gurler.   

Abstract

Genetic factors appear to be important in the pathogenesis of Behçet's disease. Although it is known to be strongly associated with HLA-B 51, the association of HLA class I antigens with specific clinical findings of the disease has not been studied extensively and the few studies are conflicting. The aim of this study was to investigate the association of HLA class I alleles with the manifestations of Behçet's disease in Turkish patients. Eighty-five patients with Behçet's disease were typed for HLA-A, B, and C antigens with the serologic, standard microlymphocytotoxicity technique. Possible associations of the HLA complex with clinical findings of Behçet's disease were examined. Statistically significant findings are as follows (P < 0.05): increased HLA-B 51 and decreased HLA-B35 frequency in patients with thrombophlebitis, increased HLA-A29 and decreased HLA-Bw6 frequency in patients with ocular involvement, decreased HLA-Cw2 frequency in patients with erythema nodosum, and decreased HLA-Cw 7 frequency in patients with genital ulceration. Of particular note, the results of this study suggest that the presence of HLA-B 51 and the absence of HLA-B35 can be regarded as laboratory risk factors of venous thrombosis in patients with Behçet's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12372094     DOI: 10.1046/j.1365-2230.2002.01060.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  8 in total

1.  Diagnostic and therapeutic challenges.

Authors:  Luiz H Lima; Eric Shakin; Hatice N Sen; Robert B Nussenblatt; Lawrence A Yannuzzi; Lee M Jampol; Emmett T Cunningham
Journal:  Retina       Date:  2010-04       Impact factor: 4.256

Review 2.  Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients.

Authors:  Ana T Rocha; Edison F Paiva; Arnaldo Lichtenstein; Rodolfo Milani; Cyrillo Filho Cavalheiro; Francisco H Maffei
Journal:  Vasc Health Risk Manag       Date:  2007

3.  Relapsing arterial aneurysms in juvenile Behçet's disease.

Authors:  Koshnaf A Antar; Harold D Keiser; Elena Peeva
Journal:  Clin Rheumatol       Date:  2004-07-17       Impact factor: 2.980

Review 4.  Etiopathogenesis of Behçet's disease with emphasis on the role of immunological aberrations.

Authors:  Violetta D Kapsimali; Meletios A Kanakis; George A Vaiopoulos; Phaedon G Kaklamanis
Journal:  Clin Rheumatol       Date:  2010-05-22       Impact factor: 2.980

5.  Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia.

Authors:  Anton Lennikov; Zemfira Alekberova; Regina Goloeva; Nobuyoshi Kitaichi; Lev Denisov; Kenichi Namba; Mitsuhiro Takeno; Yoshiaki Ishigatsubo; Nobuhisa Mizuki; Eugeny Nasonov; Susumu Ishida; Shigeaki Ohno
Journal:  Clin Rheumatol       Date:  2013-12-10       Impact factor: 2.980

6.  Histopathological Evaluation of Behçet's Disease and Identification of New Skin Lesions.

Authors:  Ozgür Gündüz
Journal:  Patholog Res Int       Date:  2011-10-18

7.  Genetics of Behçet's Disease.

Authors:  Tamer İrfan Kaya
Journal:  Patholog Res Int       Date:  2011-10-16

Review 8.  The HLA-G Immune Checkpoint Plays a Pivotal Role in the Regulation of Immune Response in Autoimmune Diseases.

Authors:  Monika Zaborek-Łyczba; Jakub Łyczba; Paulina Mertowska; Sebastian Mertowski; Anna Hymos; Martyna Podgajna; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.